How should an allergic reaction to naltrexone that causes shaking of the arms and legs and episodic arching of the head and neck be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

This is NOT an allergic reaction to naltrexone—this is a neurological emergency requiring immediate evaluation for dystonia, seizure activity, or other serious neurological conditions.

The symptoms described—episodic shaking of arms and legs with head and neck arching backwards (opisthotonus)—are not consistent with typical drug allergy or anaphylaxis. These are neurological symptoms that demand urgent medical assessment, not allergy management.

Why This Is Not an Allergic Reaction

True allergic reactions to naltrexone, when they occur, present with:

  • Urticarial rash and angioedema 1, 2
  • Cutaneous reactions like eosinophilic pustular folliculitis 3
  • Standard hypersensitivity symptoms (pruritus, flushing, respiratory symptoms)

The FDA drug label for naltrexone lists common adverse effects including tremors and twitching in less than 1% of patients, but does not describe the severe neurological presentation you're describing 1.

What These Symptoms Suggest

Episodic arching of the head and neck backwards (opisthotonus) with limb shaking suggests:

  • Dystonic reaction (though not typically caused by naltrexone)
  • Seizure activity (tonic-clonic or focal seizures)
  • Tetanus or other infectious/metabolic causes
  • Severe withdrawal syndrome if the patient has occult opioid use
  • Serotonin syndrome or other drug interactions

Naltrexone can precipitate severe withdrawal reactions in patients not completely free of opioids, which may include muscle spasms, restlessness, and agitation 1—but the specific pattern of opisthotonus is atypical.

Immediate Management

Stop naltrexone immediately and:

  1. Call 911 or activate emergency medical services 4, 5
  2. Protect the patient from injury during episodes
  3. Place patient in lateral recumbent position to protect airway
  4. Monitor vital signs continuously (blood pressure, pulse, respiratory rate, oxygen saturation)
  5. Assess for:
    • Signs of opioid withdrawal (if patient has occult opioid use)
    • Concurrent medications that could cause drug interactions
    • Metabolic abnormalities (hypocalcemia, hypomagnesemia)
    • Signs of infection

If This Were Anaphylaxis (Which It Is Not)

For completeness, if a patient had true anaphylaxis to any medication, management would be:

  • Intramuscular epinephrine 0.01 mg/kg (max 0.5 mg adults, 0.3 mg children) into anterolateral thigh 6, 4, 7, 5, 8
  • Repeat every 5-15 minutes if symptoms persist 6, 4, 7
  • Place patient supine with legs elevated (unless respiratory distress) 5, 9
  • Administer supplemental oxygen 5, 9
  • IV fluid bolus for hypotension 5, 9
  • Antihistamines and corticosteroids are adjunctive only, never first-line 9, 5, 8

Critical Next Steps

Transport to emergency department immediately for:

  • Neurological examination
  • EEG if seizure suspected
  • Metabolic panel including calcium and magnesium
  • Toxicology screen
  • Assessment for occult opioid use
  • Brain imaging if indicated

Do not rechallenge with naltrexone until the cause of these neurological symptoms is identified and the patient has been cleared by neurology.

The pattern you describe is a medical emergency requiring neurological evaluation, not allergy management. The episodic nature with opisthotonus is particularly concerning and warrants immediate hospital-level care.

References

Research

Naltrexone-induced drug eruption.

Clinical case reports, 2020

Research

Eosinophilic pustular folliculitis due to naltrexone: A case report.

Journal of the American Pharmacists Association : JAPhA, 2022

Guideline

clinical practice guideline: immunotherapy for inhalant allergy.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2024

Guideline

work group report: oral food challenge testing.

Journal of Allergy and Clinical Immunology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.